Series A · AI & Machine Learning · Madrid, Spain · Founded 2019 · 11–50 employees
Tucuvi has developed LOLA, a voice AI clinical agent that conducts autonomous phone conversations with patients to automate healthcare workflows including post-surgical follow-up, chronic disease management, and appointment scheduling. The company reports up to 80% automation in nursing follow-ups and has achieved European regulatory approval as a Class IIb Software as a Medical Device, making it the first AI platform of its kind to receive such certification. Tucuvi currently serves over 60 healthcare organizations including major partners like AstraZeneca and the UK National Health Service, with over 300,000 patient calls completed. The company just raised €17 million in Series A funding in January 2026 to expand internationally across Europe and the US.
No open roles listed right now.